Browsing by 키워드 : immunotherapy
전체 결과 27건 중 1-27 번을 표시중입니다.
- 1 Article A New Human Leukocyte Antigen Typing Algorithm Combined With Currently Available Genotyping Tools Based on Next-Generation Sequencing Data and Guidelines to Select the Most Likely Human Leukocyte Antigen Genotype 공경엽 ; 김수연 ; 김영애 ; et al 2021
- 2 Article Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials Yoon-Koo Kang ; Martin Reck ; Paul Nghiem ; et al 2022
- 3 Article Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex Dieke J van Rees ; Panagiota Bouti ; Bart Klein ; et al 2022
- 4 Article Clinical evidence and insights supporting the use of avelumab first-line maintenance treatment in patients with advanced urothelial carcinoma in the Asia-Pacific region Masatoshi Eto ; Jae-Lyun Lee ; Yen-Hwa Chang ; et al 2022
- 5 Article Comparison of RECIST 1.1 and irecist in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis 박효정 ; 김건하 ; 김경원 ; et al 2021
- 6 Article Comparison of RECIST 1.1 and irecist in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis 박효정 ; 김건하 ; 김경원 ; et al 2021
- 7 Article Correlation between tumor-associated macrophages and immune checkpoint molecule expression and its prognostic significance in cutaneous melanoma 김영재 ; 원종현 ; 이미우 ; et al 2020
- 8 Article Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study 김상위 ; 김우성 ; 윤신교 ; et al 2021
- 9 Article Enhancing adoptive T-cell therapy with fucoidan-based IL-2 delivery microcapsules Eun Young Jeon ; Da-Som Choi ; Seunghyun Choi ; et al 2022
- 10 Article Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240 류백렬 ; Abby B Siegel ; Amit S Kulkarni ; et al 2021
- 11 Article How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles 2023
- 12 Article Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry 안종화 ; 김미화 ; 송의연 ; et al 2021
- 13 Article Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry 안종화 ; 김미화 ; 송의연 ; et al 2021
- 14 Article LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells 송준선 ; Cassian Yee ; Eunho Cho ; et al 2020
- 15 Article Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy 박윤 ; 이동희 ; 최승현 ; et al 2021
- 16 Article Nivolumab as maintenance therapy following platinum-based chemotherapy in EGFR-mutant lung cancer patients after tyrosine kinase inhibitor failure: A single-arm, open-label, phase 2 trial 2023
- 17 Article Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting 김성배 ; Cynthia Villarreal-Garza ; Florencia Perazzo ; et al 2020
- 18 Article PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers Dong-Hee Lee ; Yu-Jeong Jeong ; Ju-Young Won ; et al 2022
- 19 Article PD-1 and PD-L1 expression in Kaposi sarcoma: A comparative study according to the pathological stage and clinical characteristics 김영재 ; 원종현 ; 이미우 ; et al 2021
- 20 Article Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial 2023
- 21 Article Phase I Study of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients With Pretreated Biliary Tract Cancer 오도연 ; 유창훈 ; 최혜진 ; et al 2020
-
22
dissertation
Research on the development of antibody therapeutics to increase the survival rate of pancreatic cancer patients
안세희
2022
- 23 Article Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study 배성만 ; 김예지 ; 김민주 ; et al 2021
- 24 Article Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer 2023
- 25 Article Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 홍승모 ; Aldo Scarpa ; Andrea Mafficini ; et al 2021
- 26 Article Two-year efficacy of SNK01 plus pembrolizumab for non-small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trial Hyung Jun Park ; Yong Man Kim ; Jae Seob Jung ; et al 2022
-
27
Dissertation
항암 면역치료를 위한 PBK 타겟 항암 백신 개발에 관한 연구
김혜빈
2024
1